Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.170
+0.020 (0.93%)
Oct 19, 2026, 12:02 PM EDT - Market open
Ovid Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $5 | Buy | Initiates | $5 | +130.41% | Oct 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $6 | Buy | Initiates | $6 | +176.50% | Oct 9, 2026 |
| Wedbush | Wedbush | Buy Maintains $7 | Buy | Maintains | $7 | +222.58% | Oct 8, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $7 | Buy | Initiates | $7 | +222.58% | Oct 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 → $5 | Buy | Reiterates | $4 → $5 | +130.41% | Sep 11, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $8 | Buy | Maintains | $8 | +268.66% | Sep 3, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $5 | Buy | Reiterates | $5 | +130.41% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +314.75% | Aug 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.